These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23477361)

  • 1. Proton therapy with concomitant capecitabine for pancreatic and ampullary cancers is associated with a low incidence of gastrointestinal toxicity.
    Nichols RC; George TJ; Zaiden RA; Awad ZT; Asbun HJ; Huh S; Ho MW; Mendenhall NP; Morris CG; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):498-505. PubMed ID: 23477361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric rationale and early experience at UFPTI of thoracic proton therapy and chemotherapy in limited-stage small cell lung cancer.
    Colaco RJ; Huh S; Nichols RC; Morris CG; D'Agostino H; Flampouri S; Li Z; Pham DC; Bajwa AA; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):506-13. PubMed ID: 23438357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater.
    Overman MJ; Varadhachary GR; Kopetz S; Adinin R; Lin E; Morris JS; Eng C; Abbruzzese JL; Wolff RA
    J Clin Oncol; 2009 Jun; 27(16):2598-603. PubMed ID: 19164203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity-modulated radiation therapy with concurrent chemotherapy as preoperative treatment for localized gastric adenocarcinoma.
    Chakravarty T; Crane CH; Ajani JA; Mansfield PF; Briere TM; Beddar AS; Mok H; Reed VK; Krishnan S; Delclos ME; Das P
    Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):581-6. PubMed ID: 22137021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concurrent capecitabine and upper abdominal radiation therapy is well tolerated.
    Das P; Wolff RA; Abbruzzese JL; Varadhachary GR; Evans DB; Vauthey JN; Baschnagel A; Delclos ME; Krishnan S; Janjan NA; Crane CH
    Radiat Oncol; 2006 Oct; 1():41. PubMed ID: 17062148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton therapy with concurrent chemotherapy for non-small-cell lung cancer: technique and early results.
    Hoppe BS; Flampouri S; Henderson RH; Pham D; Bajwa AA; D'Agostino H; Huh SN; Li Z; Mendenhall NP; Nichols RC
    Clin Lung Cancer; 2012 Sep; 13(5):352-8. PubMed ID: 22264659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase I-II study of postoperative capecitabine-based chemoradiotherapy in gastric cancer.
    Jansen EP; Boot H; Saunders MP; Crosby TD; Dubbelman R; Bartelink H; Verheij M; Cats A
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1424-8. PubMed ID: 17689023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.
    Crane CH; Ellis LM; Abbruzzese JL; Amos C; Xiong HQ; Ho L; Evans DB; Tamm EP; Ng C; Pisters PW; Charnsangavej C; Delclos ME; O'Reilly M; Lee JE; Wolff RA
    J Clin Oncol; 2006 Mar; 24(7):1145-51. PubMed ID: 16505434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity profile and efficacy of oral capecitabine as adjuvant chemotherapy for Chinese patients with Stage III colon cancer.
    Law CC; Fu YT; Chau KK; Choy TS; So PF; Wong KH
    Dis Colon Rectum; 2007 Dec; 50(12):2180-7. PubMed ID: 17963003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study.
    Morganti AG; Picardi V; Ippolito E; Massaccesi M; Macchia G; Deodato F; Mattiucci GC; Caravatta L; Di Lullo L; Giglio G; Tambaro R; Mignogna S; Caprino P; Ingrosso M; Sofo L; Cellini N; Valentini V
    Acta Oncol; 2010 May; 49(4):418-22. PubMed ID: 20397772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adjuvant chemoradiation therapy in adenocarcinomas of the ampulla of vater.
    Krishnan S; Rana V; Evans DB; Varadhachary G; Das P; Bhatia S; Delclos ME; Janjan NA; Wolff RA; Crane CH; Pisters PW
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):735-43. PubMed ID: 17980502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant chemo-radiotherapy in ampullary cancers.
    Sikora SS; Balachandran P; Dimri K; Rastogi N; Kumar A; Saxena R; Kapoor VK
    Eur J Surg Oncol; 2005 Mar; 31(2):158-63. PubMed ID: 15698732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of limited field radiotherapy with concurrent capecitabine in locally advanced pancreatic cancer.
    Jackson AS; Jain P; Watkins GR; Whitfield GA; Green MM; Valle J; Taylor MB; Dickinson C; Price PM; Saleem A
    Clin Oncol (R Coll Radiol); 2010 Sep; 22(7):570-7. PubMed ID: 20650619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal adenocarcinoma.
    Hong TS; Ryan DP; Borger DR; Blaszkowsky LS; Yeap BY; Ancukiewicz M; Deshpande V; Shinagare S; Wo JY; Boucher Y; Wadlow RC; Kwak EL; Allen JN; Clark JW; Zhu AX; Ferrone CR; Mamon HJ; Adams J; Winrich B; Grillo T; Jain RK; DeLaney TF; Fernandez-del Castillo C; Duda DG
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):830-8. PubMed ID: 24867540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of the botanical formulation PHY906 with capecitabine in advanced pancreatic and other gastrointestinal malignancies.
    Saif MW; Lansigan F; Ruta S; Lamb L; Mezes M; Elligers K; Grant N; Jiang ZL; Liu SH; Cheng YC
    Phytomedicine; 2010 Mar; 17(3-4):161-9. PubMed ID: 20092990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in men with large prostates (≥ 60 cm(3)) treated with definitive proton therapy for prostate cancer.
    McGee L; Mendenhall NP; Henderson RH; Morris CG; Nichols RC; Marcus RJ; Li Z; Mendenhall WM; Williams CR; Hoppe BS
    Acta Oncol; 2013 Apr; 52(3):470-6. PubMed ID: 23244673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
    Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stomach Dose-Volume Predicts Acute Gastrointestinal Toxicity in Chemoradiotherapy for Locally Advanced Pancreatic Cancer.
    Holyoake DLP; Warren DR; Hurt C; Aznar M; Partridge M; Mukherjee S; Hawkins MA
    Clin Oncol (R Coll Radiol); 2018 Jul; 30(7):418-426. PubMed ID: 29602584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Better outcome of XELOX chemotherapy in patients with advanced intestinal-type adenocarcinoma of the ampulla of Vater.
    Kim HS; Shin SJ; Kim JH; Kim H; Choi HJ
    Tohoku J Exp Med; 2013 Sep; 231(1):21-8. PubMed ID: 23994910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.